MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer

scientific article published on 20 January 2017

MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3233/CBM-161732
P698PubMed publication ID28128744

P2093author name stringMing Qi
Dongmei Liu
Shuhong Zhang
P2860cites workMicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulatorsQ24336898
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAsQ24537328
A microRNA expression signature of human solid tumors defines cancer gene targetsQ24541455
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Q24630209
Circulating microRNAs as stable blood-based markers for cancer detectionQ24652098
Treatment modalities for early gastric cancerQ26784239
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and reviewQ26785539
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Q28131668
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesQ28131780
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cellsQ28262214
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancerQ28473944
Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancerQ28541175
miR-21-mediated tumor growthQ29616149
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerQ33488159
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.Q33575825
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancerQ34998307
The microcosmos of cancerQ36432986
OncomiRs: the discovery and progress of microRNAs in cancersQ36951319
MicroRNA-21: a novel therapeutic target in human cancerQ37817633
miR-210: a therapeutic target in cancerQ38061691
MicroRNA-regulated networks: the perfect storm for classical molecular biology, the ideal scenario for systems biologyQ38078847
MicroRNA-21: a therapeutic target for reversing drug resistance in cancerQ38122420
Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosisQ38342043
Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cellsQ38342957
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiformeQ38352790
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.Q39184500
MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancerQ39413698
MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activityQ39679824
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasLQ41134742
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cellsQ41576938
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.Q53604465
P433issue4
P304page(s)451-458
P577publication date2017-01-20
P1433published inCancer BiomarkersQ2051879
P1476titleMicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer
P478volume18

Reverse Query: null

Search more.